Brief: IceCure Medical Reports Final ICE3 Breast Cancer Cryoablation Trial Results
15/04/2024 13:41
April 15 (Reuters) - Icecure Medical Ltd ICCM.O :
* ICECURE MEDICAL REPORTS FINAL ICE3 BREAST CANCER
CRYOABLATION
TRIAL RESULTS OF 100% PATIENT AND PHYSICIAN SATISFACTION AND
96.3% RECURRENCE FREE RATE: DATA SUBMITTED TO FDA REQUESTING
MARKETING AUTHORIZATION TO TREAT EARLY-STAGE BREAST CANCER
Source text for Eikon: ID:nPn3lYdW8a
Further company coverage: ICCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Icecure Medical
See all newsIcecure Medical Ltd reports results for the quarter ended June 30 - Earnings Summary
Israel's IceCure Medical H1 revenue rises on higher system, probe sales
Brief: Icecure Sio Petitions Nccn To Include Cryoablation In Breast Cancer Treatment Guidelines, Citing Icecure's FDA Clearance Of Prosense®
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:45 AM